MedTrace Logo

Oxytocin and Eating

NCT03225456 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-07-21

No results posted yet for this study

Summary

In this protocol, the investigators propose a randomised controlled trial to explore the effects of intra-nasal oxytocin administration on appetite regulation. The investigators will run a cross-over design with 60 healthy adult men.

Conditions

  • Weight Gain

Interventions

DRUG

Syntocinon

Intra-nasal oxytocin

DRUG

Placebos

Intra-nasal placebo

Sponsors & Collaborators

  • Singapore General Hospital

    collaborator OTHER

  • SingHealth Investigational Medicine Unit

    collaborator UNKNOWN

  • Yale-NUS College

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-30
Primary Completion
2018-12-31
Completion
2019-01-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03225456 on ClinicalTrials.gov